Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study

NEW YORK, March 12, 2024 -- Psyence Group Inc , a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to...

Related Keywords

Melbourne ,Victoria ,Australia ,United States ,Canada ,United Kingdom ,Canadian ,Australian ,Jody Aufrichtig ,Psyence Biomed ,Neil Maresky ,Jeremy Feffer ,Psyence Biomedical Ltd ,Twitter ,Contract Research Organization ,Psyence Group ,Linkedin ,Instagram ,Psyence Group Inc ,Psyence Australia Pty Ltd ,Newcourt Acquisition Corp ,Nasdaq ,Australian Health Research Ethics Committee ,Canadian Securities Exchange ,World Health Organization ,Pty Ltd ,Group Inc ,Psyence Australia ,Adjustment Disorder ,World Health ,Business Combination ,Executive Chairman ,Psyence Biomedical Ltd Chief Executive Officer ,Hamilton Anxiety Rating Scale ,Sud Agrawal ,Psyence Production ,Psyence Function ,Southern Africa ,Private Securities Litigation Reform Act ,Registration Statement ,